What is the current stock price of Lunai Bioworks Inc. (RENB)?

As of the latest market data, Lunai Bioworks Inc. (RENB) is trading at $1.42. The stock has seen a loss of 0.00% today.

Does Lunai Bioworks Inc. (RENB) pay a dividend?

Based on current data, Lunai Bioworks Inc. does not have a confirmed active dividend policy.

What is the market cap of Lunai Bioworks Inc.?

The current market capitalization of Lunai Bioworks Inc. (RENB) is approximately unavailable.

RENB

Lunai Bioworks Inc.·Healthcare

1.42

0.000%(+0.00)

Market Closed

1.54

8.451%(+0.12)

After Hours

Last Updated: — ET

52W L: $1.1252W H: $21.00

Company Profile

Lunai Bioworks, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2018-02-07

Beta

0.53

Websiterenovarogroup.com↗